AGIOS PHARMACEUTICALS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $72 FROM $73

Reuters2026/10/22 11:12

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

QuantumScape Grants CFO Kevin Hettrich 478,468 Restricted Stock Units

Bitget•2026/11/07 00:15

MP Materials posts surprise adjusted profit

Mining.com•2026/11/06 23:42

BeInCrypto and Coinhold Wallet to Host AMA on Stablecoins and Inflation in Latin America

BeInCrypto•2026/11/06 20:27

Elme Communities Deregisters Common Shares of Beneficial Interest

Bitget•2026/11/06 19:00